Cost-Effectiveness Analysis of Fulvestrant in the Treatment of Metastatic Breast Cancer in Second-Line Chemotherapy

Value Health. 2014 Nov;17(7):A637. doi: 10.1016/j.jval.2014.08.2289. Epub 2014 Oct 26.
No abstract available